Travere Therapeutics Inc (TVTX) saw an uptrend of 4.51% in the recent trading with $16.68 being its most recent. The current price level -34.05% lower than the highest price of $25.29 marked by the stock while trading over the past 52-weeks, whereas it is 110.31% higher than the lowest price of $7.93 the company dropped to over past 52-weeks. The latest news story on TVTX appeared in (Business Wire) under the title “Travere Therapeutics to Participate at Upcoming Investor Conferences” on.
Looking into the simple moving average, Travere Therapeutics Inc (TVTX)’s stock stands at a SMA-50 of $15.38 while that of 5-day is reading $15.84.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and TVTX’s SMA-200 as of now is $18.00.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 8 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.25 for the stock.
Travere Therapeutics Inc Earnings – What Happened With TVTX
Coming around sales and income figures on TVTX Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Travere Therapeutics Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 88.79 million. TVTX does have institutional investors; and they hold 115.48% of the stock.
As on 2024-06-30, BLACKROCK INC. was the top most holder in Travere Therapeutics Inc (NASDAQ:TVTX) with an ownership of 7.64 million shares of the company or 9.8642 of the stake worth $62.84 million. The filing also reveals ARMISTICE CAPITAL, LLC as the second largest holder in the company with a control over 9.6774 of the outstanding shares. Its stake is worth $61.65 million for having 7.5 million shares in hand.
DEEP TRACK CAPITAL, LP also came holding a key position in the company during the recent quarter and it now holds 9.5096 of the outstanding shares. With this there are now 295.0 institutions which have possession in TVTX’s shares.
Key Metrics forTVTX
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Travere Therapeutics Inc has a debt to equity ratio of 12.20.